adplus-dvertising
Connect with us

Business

Mixing coronavirus vaccines without necessary data ‘a huge gamble,’ experts say – Global News

Published

 on


Different vaccines to protect against the novel coronavirus shouldn’t be mixed-and-matched, despite Britain’s recent decision to allow the practice to be used in rare occasions, health experts say.

Mixing different coronavirus vaccines without any data to suggest the safety and efficacy of the practice is “a huge gamble,” Dr. Colin Furness, an infection control epidemiologist and assistant professor at the University of Toronto said.

“I think it’s irresponsible … it’s unethical because we don’t know what that does,” he said. “We don’t know what the effectiveness is, we don’t know what the side effects are.”

300x250x1

Read more:
Britain to allow coronavirus vaccine mixing on rare occasions

Dr. Isaac Bogoch, an infectious diseases faculty member at the University of Toronto said while there may be “some theoretical reasons” as to why vaccine mixing “may provide decent protection to COVID-19 infections,” the data is not yet conclusive.

Story continues below advertisement

“Until we see better data to support that, I don’t think we’re going to see any such activity in Canada,” he said.


Click to play video 'Vaccine rollout pace criticized as U.S. tops 20 million cases'



2:27
Vaccine rollout pace criticized as U.S. tops 20 million cases


Vaccine rollout pace criticized as U.S. tops 20 million cases

The comments come after Britain released new guidelines on New Year’s Eve which will allow people seeking their second dose to be given shots of different COVID-19 vaccines on rare occasions.

“(If) the same vaccine is not available, or if the first product received is unknown, it is reasonable to offer one dose of the locally available product to complete the schedule,” according to the guidelines.

Mary Ramsay, head of immunizations at Public Health England, said this would only happen on extremely rare occasions, and that the government was not recommending the mixing of vaccines, which require at least two doses given several weeks apart.

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

She said “every effort should be made to give them the same vaccine.

Story continues below advertisement

“But where this is not possible it is better to give a second dose of another vaccine than not at all,” she said.

Read more:
Cabbage, cavemen and miracle cures: how fast-moving COVID-19 science can confuse the public

What has Health Canada said?

Health Canada’s National Advisory Committee on Immunization (NACI) currently recommends that the vaccine series “be completed with the same COVID-19 vaccine product.”

“Currently, no data exists on the interchangeability of COVID-19 vaccines,” the agency’s website read.

However, according to NACI, if the vaccine used for a previous dose is “not known, or not available, attempts should be made to complete the vaccine in series with a similar type of COVID-19 vaccine (e.g. mRNA vaccine).”

“In the context of limited COVID-19 vaccine supply and the absence of evidence on interchangeability of COVID-19 vaccines, the previous dose may be counted, and the series need not be restarted,” the website read.


Click to play video 'New COVID-19 guidelines released for pregnant women, future moms'



2:45
New COVID-19 guidelines released for pregnant women, future moms


New COVID-19 guidelines released for pregnant women, future moms – Dec 25, 2020

The agency said “active surveillance of effectiveness and safety of this mixed schedule will be important in these individuals,” adding that “accurate recording of vaccines received will be critical.”

Story continues below advertisement

According to the NACI, the agency will “continue to monitor the evidence” and will update its recommendations as needed.

To date, Health Canada has approved two coronavirus vaccines for use across the country. Both are mRNA vaccines, and require two doses to provide around 95 per cent protection from COVID-19.

Read more:
‘Real tension’: Should all coronavirus vaccine volunteers now get the real thing?

The Pfizer-BioNTech vaccine requires two shots to be administered 21 days apart, while doses of the Moderna vaccine are to be administered 28 days apart.

Bogoch said we have “good data” on these vaccines, and how they are to be administered.

Asked if there are any circumstances in which Canada should allow different vaccines to be mixed-and-matched before data is available, Bogoch said: “no.”

“I’m not entirely sure outside of a clinical trial what the role would be for conducting this type of activity,” he said.


Click to play video 'COVID-19 vaccine committee’s new advice on who should get inoculated first'



2:23
COVID-19 vaccine committee’s new advice on who should get inoculated first


COVID-19 vaccine committee’s new advice on who should get inoculated first – Dec 1, 2020

Furness also said vaccines should not be mixed unless in a lab setting, where participants have given their informed consent.

Story continues below advertisement

“If you want to do a trial to try them out, sure,” he said. “But that’s going to take many months.”

Anything else, Furness said, would be “experimental.”

“The human history is really littered with experimenting on people without the understanding that they’re being experimented on,” he said. “And that’s really not OK.”

Read more:
Canada has approved 2 coronavirus vaccines. How are other candidates progressing?

For now, Bogoch said we should focus on rolling out the approved vaccines as quickly as possible, in the manner in which they are meant to be administered.

“The goal is to have as few vaccines in freezers as possible and get the needles in arms quickly as possible to the highest risk groups and prevent death and suffering,” he said.

–With files from Reuters

© 2021 Global News, a division of Corus Entertainment Inc.

Let’s block ads! (Why?)

728x90x4

Source link

Continue Reading

Business

Tesla Promises Cheap EVs by 2025 | OilPrice.com – OilPrice.com

Published

 on



Tesla Promises Cheap EVs by 2025 | OilPrice.com



300x250x1


Charles Kennedy

Charles Kennedy

Charles is a writer for Oilprice.com

More Info

Related News

Tesla

Tesla has promised to start selling cheaper models next year, days after a Reuters report revealed that the company had shelved its plans for an all-new Tesla that would cost only $25,000.

The news that Tesla was scrapping the Model 2 came amid a drop in sales and profits, and a decision to slash a tenth of the company’s global workforce. Reuters also noted increased competition from Chinese EV makers.

Tesla’s deliveries slumped in the first quarter for the first annual drop since the start of the pandemic in 2020, missing analyst forecasts by a mile in a sign that even price cuts haven’t been able to stave off an increasingly heated competition on the EV market.

Profits dropped by 50%, disappointing investors and leading to a slump in the company’s share prices, which made any good news urgently needed. Tesla delivered: it said it would bring forward the date for the release of new, lower-cost models. These would be produced on its existing platform and rolled out in the second half of 2025, per the BBC.

Reuters cited the company as warning that this change of plans could “result in achieving less cost reduction than previously expected,” however. This suggests the price tag of the new models is unlikely to be as small as the $25,000 promised for the Model 2.

The decision is based on a substantially reduced risk appetite in Tesla’s management, likely affected by the recent financial results and the intensifying competition with Chinese EV makers. Shelving the Model 2 and opting instead for cars to be produced on existing manufacturing lines is the safer move in these “uncertain times”, per the company.

Tesla is also cutting prices, as many other EV makers are doing amid a palpable decline in sales in key markets such as Europe, where the phaseout of subsidies has hit demand for EVs seriously. The cut is of about $2,000 on all models that Tesla currently sells.

By Charles Kennedy for Oilprice.com

More Top Reads From Oilprice.com:

Join the discussion | Back to homepage

Related posts

Adblock test (Why?)

728x90x4

Source link

Continue Reading

Business

Why the Bank of Canada decided to hold interest rates in April – Financial Post

Published

 on


Article content

Divisions within the Bank of Canada over the timing of a much-anticipated cut to its key overnight interest rate stem from concerns of some members of the central bank’s governing council that progress on taming inflation could stall in the face of stronger domestic demand — or even pick up again in the event of “new surprises.”

“Some members emphasized that, with the economy performing well, the risk had diminished that restrictive monetary policy would slow the economy more than necessary to return inflation to target,” according to a summary of deliberations for the April 10 rate decision that were published Wednesday. “They felt more reassurance was needed to reduce the risk that the downward progress on core inflation would stall, and to avoid jeopardizing the progress made thus far.”

Article content

300x250x1

Others argued that there were additional risks from keeping monetary policy too tight in light of progress already made to tame inflation, which had come down “significantly” across most goods and services.

Some pointed out that the distribution of inflation rates across components of the consumer price index had approached normal, despite outsized price increases and decreases in certain components.

“Coupled with indicators that the economy was in excess supply and with a base case projection showing the output gap starting to close only next year, they felt there was a risk of keeping monetary policy more restrictive than needed.”

In the end, though, the central bankers agreed to hold the rate at five per cent because inflation remained too high and there were still upside risks to the outlook, albeit “less acute” than in the past couple of years.

Despite the “diversity of views” about when conditions will warrant cutting the interest rate, central bank officials agreed that monetary policy easing would probably be gradual, given risks to the outlook and the slow path for returning inflation to target, according to the summary of deliberations.

Article content

They considered a number of potential risks to the outlook for economic growth and inflation, including housing and immigration, according to summary of deliberations.

The central bankers discussed the risk that housing market activity could accelerate and further boost shelter prices and acknowledged that easing monetary policy could increase the likelihood of this risk materializing. They concluded that their focus on measures such as CPI-trim, which strips out extreme movements in price changes, allowed them to effectively look through mortgage interest costs while capturing other shelter prices such as rent that are more reflective of supply and demand in housing.

Recommended from Editorial

  1. Bank of Canada governor Tiff Macklem during a news conference in Ottawa.

    BoC ‘committed to finishing the job’ on inflation:‘ Macklem

  2. Bank of Canada governor Tiff Macklem at a press conference in Ottawa.

    Time for Macklem to turn before it’s too late

  3. Canada's inflation rate picked up slightly in March, but the consumer price index (CPI) release suggested that core inflation continued to slow.

    ‘Welcome news’ on inflation raises odds of rate cut

They also agreed to keep a close eye on immigration in the coming quarters due to uncertainty around recent announcements by the federal government.

“The projection incorporated continued strong population growth in the first half of 2024 followed by much softer growth, in line with the federal government’s target for reducing the share of non-permanent residents,” the summary said. “But details of how these plans will be implemented had not been announced. Governing council recognized that there was some uncertainty about future population growth and agreed it would be important to update the population forecast each quarter.”

• Email: bshecter@nationalpost.com

Bookmark our website and support our journalism: Don’t miss the business news you need to know — add financialpost.com to your bookmarks and sign up for our newsletters here.

Share this article in your social network

Adblock test (Why?)

728x90x4

Source link

Continue Reading

Business

Meta shares sink after it reveals spending plans – BBC.com

Published

 on


Woman looks at phone in front of Facebook image - stock shot.

Shares in US tech giant Meta have sunk in US after-hours trading despite better-than-expected earnings.

The Facebook and Instagram owner said expenses would be higher this year as it spends heavily on artificial intelligence (AI).

Its shares fell more than 15% after it said it expected to spend billions of dollars more than it had previously predicted in 2024.

300x250x1

Meta has been updating its ad-buying products with AI tools to boost earnings growth.

It has also been introducing more AI features on its social media platforms such as chat assistants.

The firm said it now expected to spend between $35bn and $40bn, (£28bn-32bn) in 2024, up from an earlier prediction of $30-$37bn.

Its shares fell despite it beating expectations on its earnings.

First quarter revenue rose 27% to $36.46bn, while analysts had expected earnings of $36.16bn.

Sophie Lund-Yates, lead equity analyst at Hargreaves Lansdown, said its spending plans were “aggressive”.

She said Meta’s “substantial investment” in AI has helped it get people to spend time on its platforms, so advertisers are willing to spend more money “in a time when digital advertising uncertainty remains rife”.

More than 50 countries are due to have elections this year, she said, “which hugely increases uncertainty” and can spook advertisers.

She added that Meta’s “fortunes are probably also being bolstered by TikTok’s uncertain future in the US”.

Meta’s rival has said it will fight an “unconstitutional” law that could result in TikTok being sold or banned in the US.

President Biden has signed into law a bill which gives the social media platform’s Chinese owner, ByteDance, nine months to sell off the app or it will be blocked in the US.

Ms Lund-Yates said that “looking further ahead, the biggest risk [for Meta] remains regulatory”.

Last year, Meta was fined €1.2bn (£1bn) by Ireland’s data authorities for mishandling people’s data when transferring it between Europe and the US.

And in February of this year, Meta chief executive Mark Zuckerberg faced blistering criticism from US lawmakers and was pushed to apologise to families of victims of child sexual exploitation.

Ms Lund-Yates added that the firm has “more than enough resources to throw at legal challenges, but that doesn’t rule out the risks of ups and downs in market sentiment”.

Adblock test (Why?)

728x90x4

Source link

Continue Reading

Trending